Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS)

CNY 16.08

(0.06%)

Revenue Summary of Zhejiang Shengda Bio-Pharm Co., Ltd.

  • Zhejiang Shengda Bio-Pharm Co., Ltd.'s latest annual revenue in 2023 was 727.4 Million CNY , down -1.44% from previous year.
  • Zhejiang Shengda Bio-Pharm Co., Ltd.'s latest quarterly revenue in 2024 Q3 was 224.39 Million CNY , up 13.84% from previous quarter.
  • Zhejiang Shengda Bio-Pharm Co., Ltd. reported a annual revenue of 738.01 Million CNY in annual revenue 2022, down -6.55% from previous year.
  • Zhejiang Shengda Bio-Pharm Co., Ltd. reported a annual revenue of 789.73 Million CNY in annual revenue 2021, down -8.95% from previous year.
  • Zhejiang Shengda Bio-Pharm Co., Ltd. reported a quarterly revenue of 224.39 Million CNY for 2024 Q3, up 13.84% from previous quarter.
  • Zhejiang Shengda Bio-Pharm Co., Ltd. reported a quarterly revenue of 197.11 Million CNY for 2024 Q2, up 7.96% from previous quarter.

Annual Revenue Chart of Zhejiang Shengda Bio-Pharm Co., Ltd. (2023 - 2012)

Historical Annual Revenue of Zhejiang Shengda Bio-Pharm Co., Ltd. (2023 - 2012)

Year Revenue Revenue Growth
2023 727.4 Million CNY -1.44%
2022 738.01 Million CNY -6.55%
2021 789.73 Million CNY -8.95%
2020 867.31 Million CNY 67.06%
2019 519.14 Million CNY 5.37%
2018 492.7 Million CNY -3.12%
2017 508.56 Million CNY 5.48%
2016 482.14 Million CNY -10.12%
2015 536.42 Million CNY 40.83%
2014 380.89 Million CNY -4.48%
2013 398.77 Million CNY -11.24%
2012 449.25 Million CNY 0.0%

Peer Revenue Comparison of Zhejiang Shengda Bio-Pharm Co., Ltd.

Name Revenue Revenue Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 9.65 Billion CNY 92.466%
Yabao Pharmaceutical Group Co., Ltd 2.9 Billion CNY 75.001%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 75.51 Billion CNY 99.037%
Harbin Pharmaceutical Group Co., Ltd. 15.33 Billion CNY 95.258%
Tasly Pharmaceutical Group Co., Ltd 8.54 Billion CNY 91.488%
Zhejiang Medicine Co., Ltd. 7.79 Billion CNY 90.667%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 8.22 Billion CNY 91.153%
Lionco Pharmaceutical Group Co.,Ltd. 196.83 Million CNY -269.558%
Humanwell Healthcare (Group) Co.,Ltd. 24.33 Billion CNY 97.011%
Ginwa Enterprise (Group) Inc. 565.4 Million CNY -28.653%
Joincare Pharmaceutical Group Industry Co.,Ltd. 16.64 Billion CNY 95.63%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 644.97 Million CNY -12.781%
China Animal Husbandry Industry Co., Ltd. 5.4 Billion CNY 86.545%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 860.93 Million CNY 15.51%
Zhejiang Huahai Pharmaceutical Co., Ltd. 8.21 Billion CNY 91.142%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.87 Billion CNY 61.15%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.21 Billion CNY 40.205%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 5.52 Billion CNY 86.831%
Chongqing Taiji Industry(Group) Co.,Ltd 15.43 Billion CNY 95.287%
HPGC Renmintongtai Pharmaceutical Corporation 10.38 Billion CNY 92.999%
Nanjing Well Pharmaceutical Group Co.,Ltd. 1.15 Billion CNY 37.067%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 3.73 Billion CNY 80.521%
Henan Lingrui Pharmaceutical Co., Ltd. 3.31 Billion CNY 78.034%
Shenzhen Chipscreen Biosciences Co., Ltd. 515.78 Million CNY -41.029%
Guizhou Yibai Pharmaceutical Co., Ltd. 2.77 Billion CNY 73.815%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 4.86 Billion CNY 85.057%
Zhongzhu Healthcare Holding Co.,Ltd 580.05 Million CNY -25.402%
Beijing Tongrentang Co., Ltd 17.86 Billion CNY 95.927%
KPC Pharmaceuticals, Inc. 7.62 Billion CNY 90.465%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 845.34 Million CNY 13.951%
North China Pharmaceutical Company Ltd. 10.12 Billion CNY 92.812%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 10.22 Billion CNY 92.884%
Tibet Weixinkang Medicine Co., Ltd. 1.32 Billion CNY 45.004%
China National Medicines Corporation Ltd. 49.69 Billion CNY 98.536%
Zhejiang Hisun Pharmaceutical Co., Ltd. 10.37 Billion CNY 92.988%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.13 Billion CNY 76.821%
ChengDu ShengNuo Biotec Co.,Ltd. 430.98 Million CNY -68.777%
Dali Pharmaceuticalco.,Ltd 87.26 Million CNY -733.512%
Changchun BCHT Biotechnology Co. 1.81 Billion CNY 59.848%
Shanghai Jiaoda Onlly Co.,Ltd 291.91 Million CNY -149.18%
Jiang Zhong Pharmaceutical Co.,Ltd 4.32 Billion CNY 83.191%
Mayinglong Pharmaceutical Group Co., LTD. 3.13 Billion CNY 76.81%
Cisen Pharmaceutical Co., Ltd. 4.46 Billion CNY 83.699%
Hunan Warrant Pharmaceutical Co.,Ltd 1.43 Billion CNY 49.231%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 41.39 Billion CNY 98.243%
Jianmin Pharmaceutical Group Co.,Ltd. 4.18 Billion CNY 82.615%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.62 Billion CNY 55.334%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.09 Billion CNY 76.509%
Guobang Pharma Ltd. 5.34 Billion CNY 86.402%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 672.96 Million CNY -8.09%
Kangmei Pharmaceutical Co., Ltd. 4.87 Billion CNY 85.076%
Shandong Buchang Pharmaceuticals Co., Ltd. 13.24 Billion CNY 94.508%
Zhejiang Starry Pharmaceutical Co.,Ltd. 2.17 Billion CNY 66.595%
Henan Taloph Pharmaceutical Stock Co.,Ltd 2.06 Billion CNY 64.858%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 3.79 Billion CNY 80.85%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.93 Billion CNY 81.497%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 932.12 Million CNY 21.962%
Shanghai Shyndec Pharmaceutical Co., Ltd. 11.93 Billion CNY 93.904%
Shanghai Yizhong Pharmaceutical Co., Ltd. 360.25 Million CNY -101.915%
Tibet Rhodiola Pharmaceutical Holding Co. 3.09 Billion CNY 76.506%
Sichuan Huiyu Pharmaceutical Co., Ltd. 920.34 Million CNY 20.964%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 671.62 Million CNY -8.305%
CanSino Biologics Inc. 345.18 Million CNY -110.731%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 2.17 Billion CNY 66.542%
Shandong Lukang Pharmaceutical Co.,Ltd. 6.14 Billion CNY 88.166%